Patents for 20 drugs set to expire in 3Q

Published: 2013-06-11 07:00:00

Updated: 2013-06-11 07:00:00

A total of 20 best-selling medicines here will face their patent expirations in the third quarter of the year, according to data released by the Ministry of Food and Drug Safety (MFDS) said Sunday.

Large pharmaceutical companies may not be able to depend on these drugs to sustain them.

With...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK